DCIS and LCIS are confusing and outdated terms. They should be abandoned infavor of ductal intraepithelial neoplasia (DIN) and lobular intraepithelial neoplasia (LIN)

Breast

Volumn 22, Issue 4, 2013, Pages 431-435

  Galimberti, Viviana ^a   Monti, Simonetta ^a   Mastropasqua, Mauro Giuseppe ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Breast cancer; DCIS; DIN; LCIS; LIN; Pathological classification

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST CARCINOMA; BREAST RECONSTRUCTION; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CONFUSION; DUCTAL INTRAEPITHELIAL NEOPLASIA; HEALTH PRACTITIONER; HUMAN; INTRADUCTAL CARCINOMA; LOBULAR INTRAEPITHELIAL NEOPLASIA; MASTECTOMY; MEDICAL TERMINOLOGY; METASTASIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RISK REDUCTION; TUMOR CLASSIFICATION; TUMOR DIFFERENTIATION;

EID: 84879780290     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.04.010     Document Type: Article

References (49)

1. Tavassoli F.A. Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 1998, 11:140-154.
2. Tavassoli F.A. Breast pathology: rationale for adopting the ductal intraepithelial neoplasia (DIN) classification. Nat Clin Pract Oncol 2005, 2:116-117.
3. Arpino G., Laucirica R., Elledge R.M. Premalignant and in situ breast disease: biology and clinical implications. Ann Intern Med 2005, 143(6):446-457.
4. Morrow M., O'Sullivan M.J. The dilemma of DCIS. Breast 2007, 16(Suppl. 2):S59-S62.
5. Erbas B., Provenzano E., Armes J., Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 2006, 97(2):135-144.
6. Leonard G.D., Swain S.M. Ductal carcinoma in situ, complexities and challenges. JNatl Cancer Inst 2004, 96(12):906-920.
7. Page D.L., Kidd T.E., Dupont W.D., Simpson J.F., Rogers L.W. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991, 22:1232-1239.
8. Bratthauer G.L., Tavassoli F.A. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002, 440:134-138.
9. Bluman L.G., Borstelmann N.A., Rimer B.K., Iglehart J.D., Winer E.P. Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. JWomens Health Gend Based Med 2001, 10(6):589-598.
10. Rakovitch E., Franssen E., Kim J., Ackerman I., Pignol J.P., Paszat L., et al. Acomparison of risk perception and psychological morbidity in women with ductal carcinoma in situ and early invasive breast cancer. Breast Cancer Res Treat 2003, 77(3):285-293.
11. Partridge A., Adloff K., Blood E., Dees E.C., Kaelin C., Golshan M., et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. JNatl Cancer Inst 2008, 100(4):243-251. Epub 2008 Feb 12.
12. De Morgan S., Redman S., White K.J., Cakir B., Boyages J. "Well, have I got cancer or haven't I?" the psycho-social issues for women diagnosed with ductal carcinoma in situ. Health Expect 2002, 5(4):310-318.
13. Prinjha S., Evans J., McPherson A. Women's information needs about ductal carcinoma in situ before mammographic screening and after diagnosis: a qualitative study. JMed Screen 2006, 13(3):110-114.
14. Kennedy F., Harcourt D., Rumsey N. The challenge of being diagnosed and treated for ductal carcinoma in situ (DCIS). Eur J Oncol Nurs 2008, 12(2):103-111. Epub 2007 Nov 26.
15. van Gestel Y.R., Voogd A.C., Vingerhoets A.J., Mols F., Mols F., Nieuwenhuijzen G.A., et al. Acomparison of quality of life, disease impact and risk perception in women with invasive breast cancer and ductal carcinoma in situ. Eur J Cancer 2007, 43(3):549-556. Epub 2006 Nov 30.
16. Brown M., Koch T., Webb C. Information needs of women with non invasive breast cancer. JClin Nurs 2000, 9:713-722.
17. Nápoles-Springer A.M., Livaudais J.C., Bloom J., Hwang S., Kaplan C.P. Information exchange and decision making in the treatment of Latina and white women with ductal carcinoma in situ. JPsychosoc Oncol 2007, 25(4):19-36.
18. Fisher E.R., Dignam J., Tan-Chiu E., Costantino J., Fisher B., Paik S., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999, 86(3):429-438.
19. Virnig B.A., Tuttle T.M., Shamliyan T., Kane R.L. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment and outcomes. JNatl Cancer Inst 2010, 102(3):170-178.
20. Schwartz L.M., Woloshin S., Welch H.G. Risk communication in clinical practice:putting cancer in context. JNatl Cancer Inst Monogr 1999, 25:124-133.
21. de Roos M.A., van der Vegt B., de Vries J., Wesseling J., de Bock G.H. Pathological and biological differences between screen-detected and interval ductal carcinoma in situ of the breast. Ann Surg Oncol 2007, 14(7):2097-2104.
22. Schnitt S. The diagnosis and management of pre-invasive breast disease: flat epithelial atypia-classification, pathologic features and clinical significance. Breast Cancer Res 2003, 5(5):263-268.
23. Pathology and genetics of tumours of the breast and female genital organs 2003, IARC Press, International Agency for Research on Cancer, Lyon. F.A. Tavassoli, P. Devilee (Eds.).
24. Essentials of diagnostic breast pathology. A practical approach 2007, Springer-Verlag, Berlin. F. Moninfar (Ed.).
25. Aulmann S., Braun L., Mietzsch F., Longerich T., Penzel R., Schirmacher P., et al. Transitions between flat epithelial atypia and low-grade ductal carcinoma in situ of the breast. Am J Surg Pathol 2012, 36:1247.
26. Kennedy F., Harcourt D., Rumsey N. Perceptions of ductal carcinoma in situ (DCIS) among UK health professionals. Breast 2009, 18(2):89-93. Epub 2009 Feb 20.
27. Sackey H., Sandelin K., Frisell J., Wickman M., Brandberg Y. Ductal carcinoma in situ of the breast. Long-term follow-up of health-related quality of life, emotional reactions and body image. Eur J Surg Oncol 2010, 36(8):756-762. Epub 2010 Jul 3. 10.1016/j.ejso.2010.06.016.
28. De Morgan S., Redman S., D'Este C., Rogers K. Knowledge, satisfaction with information, decisional conflict and psychological morbidity amongst women diagnosed with ductal carcinoma in situ (DCIS). Patient Educ Couns 2011, 84(1):62-68. Epub 2010 Aug 9. 10.1016/j. pec.2010.07.002.
29. De Morgan S.E., Butow P.N., Lobb E.A., Price M.A., Nehill C. Development and pilot testing of a communication aid to assist clinicians to communicate with women diagnosed with ductal carcinoma in situ (DCIS). Support Care Cancer 2011, 19(5):717-723. 10.1007/s00520-010-1040-5.
30. Gerrity M.S., Earp J.L., DeVellis R.F., Light D.W. Uncertainty and professional work: perceptions of physicians in clinical practice. Am J Sociol 1992, 97:1022-1051.
31. Katz J. Why doctors don't disclose uncertainly. Hastings Cent Rep 1984, 14:35-44.
32. Gordon G.H., Joos S.K., Byrne J. Physician expressions of uncertainly during patient encounters. Patient Educ Couns 2000, 40:50-65.
33. Odgen J., Fuks K., Gardner M., Johnson S., Mc Lean M., Martin P., et al. Doctors expression of uncertainly and patient confidence. Patient Educ Couns 2002, 48:171-176.
34. Godby C.J. Women's attitudes to false positive mammography results. Aformerly clueless patient responds. Br Med J 2000, 321(7273):1409-1410.
35. Lewis J.L., Lee D.Y., Tartter P.I. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast. Ann Surg Oncol 2012, 19:4124.
36. Apple S.K., Matin M., Olsen E.P., Moatamed N.A. Significance of lobular intraepithelial neoplasia at margins of breast conservation specimens: a report of 38 cases and literature review. Diagn Pathol 2010, 5:54. 10.1186/1746-1596-5-54.
37. Anderson B.O., Calhoun K.E., Rosen E.L. Evolving concepts in the management of lobular neoplasia. JNatl Compr Canc Netw 2006, 4(5):511-522.
38. Davis K.L., Barth R.J., Gui J., Dann E., Eisenberg B., Rosenkranz K. Use of MRI in preoperative planning for women with newly diagnosed DCIS: risk or benefit?. Ann Surg Oncol 2012, 19(10):3270-3274. 10.1245/s10434-012-2548-3.
39. Bijker N., Meijnen P., Peterse J.L., Bogaerts J., et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. JClin Oncol 2006, 24(21):3381-3387. EORTC Breast Cancer Cooperative Group, EORTC Radiotherapy Group.
40. Holmberg L., Garmo H., Granstrand B., Ringberg A., Arnesson L.G., Sandelin K., et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. JClin Oncol 2008, 26(8):1247-1252. 10.1200/JCO.2007.12.7969.
41. Houghton J., George W.D., Cuzick J., Duggan C., Fentiman I.S., Spittle M., UK Coordinating Committee on Cancer Research; Ductal Carcinoma in situ Working Party; DCIS trialists in the UK, Australia, and New Zealand Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003, 362(9378):95-102.
42. Correa C., McGale P., Taylor C., Wang Y., Clarke M., et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. Natl Cancer Inst Monogr 2010, 2010(41):162-177. Early Breast Cancer Trialists' Collaborative Group (EBCTCG). 10.1093/jncimonographs/lgq039.
43. Goldhirsch A., Wood W.C., Coates A.S., Gelber R.D., Thürlimann B., Senn H.J., Panel members Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol 2011, 22(8):1736-1747. 10.1093/annonc/mdr304.
44. Park S.S., Grills I.S., Chen P.Y., Kestin L.L., Ghilezan M.I., Wallace M., et al. Accelerated partial breast irradiation for pure ductal carcinoma in situ. Int J Radiat Oncol Biol Phys 2011, 81(2):403-408. 10.1016/j.ijrobp.2010.05.030.
45. Silverstein M.J., Lagios M.D., Craig P.H., Waisman J.R., Lewinsky B.S., Colburn W.J., et al. Aprognostic index for ductal carcinoma in situ of the breast. Cancer 1996, 77:2267-2274.
46. Naoura I., Mazouni C., Ghanimeh J., Leymarie N., Garbay J.R., Karsenti G., et al. Factors influencing the decision to offer immediate breast reconstruction after mastectomy for ductal carcinoma in situ (DCIS): the Institut Gustave Roussy Breast Cancer Study Group experience. Breast 2013, pii: S0960-9776(13)00004-0. 10.1016/j.breast.2013.01.002.
47. Farante G., Galimberti V., Zurrida S., Veronesi P., Luini A., Veronesi U. No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN). Eur J Cancer 2010, 46(3):476-478. 10.1016/j.ejca.2009.12.004.
48. Nofech-Mozes S., Spayne J., Rakovitch E., Hanna W. Prognostic and predictive molecular markers in DCIS: a review. Adv Anat Pathol 2005, 12(5):256-264.
49. Veronesi U., Zurrida S., Viale G., Galimberti V., Arnone P., Nolè F. Rethinking TNM: a breast cancer classification to guide to treatment and facilitate research. Breast J 2009, 15(3):291-295. 10.1111/j.1524-4741.2009.00719.x.